Dihydroberberine, a hydrogenated derivative of Berberine (BBR), exerts anti-inflammatory effect via dual modulation of NF-κB and MAPK signaling pathways.
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Dihydroberberine, a hydrogenated derivative of Berberine (BBR), exerts anti-inflammatory effect via dual modulation of NF-κB and MAPK signaling pathways.
[1] Lihua Tan, et al. Int Immunopharmacol . 2019 Oct;75:105802.
没有评价数据